Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults

<b>Background/Objectives:</b> Individuals with immunocompromising conditions are at high risk of developing severe respiratory syncytial virus (RSV) illness. This phase 3, single-arm study assessed the safety and immunogenicity of the bivalent RSV prefusion F protein−based (RSVpreF) 120-µg vaccine i...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Natalia Castillo Almeida, Lalitha Parameswaran, Elliot N. DeHaan, Hayley Wyper, Farah Rahman, Qin Jiang, Wen Li, Michael Patton, Maria Maddalena Lino, Zaynah Majid-Mahomed, Elissa Malkin, Matthew Davis, William J. Towner, Kapil Saharia, Kumar Ilangovan, Elena Kalinina, David Cooper, Kena A. Swanson, Annaliesa S. Anderson, Alejandra Gurtman, Iona Munjal
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-03-01
Colecção:	Vaccines
Assuntos:	RSVpreF RSV immunogenicity safety immunocompromised renally impaired
Acesso em linha:	https://www.mdpi.com/2076-393X/13/3/328
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!